Thomas M Moriarty
CIK 1412221 · EVP, M&A and Corporate Affairs · last filed 2026-08-11
Thomas M Moriarty is an EVP, M&A and Corporate Affairs who has filed 76 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for ACI, was dated Aug 11, 2026. Across all open-market trades the lifetime net is −$73.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $51.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$51.92M
4
76
-$73.28M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACI | EVP, M&A and Corporate Affairs | 617,892 | $12.12 | $7.49M | $1.96M | 26 | 2026-08-11 |
| CVS | EVP & General Counsel | 474,393 | $93.65 | $44.43M | -$66.46M | 30 | 2023-01-04 |
| CELGENE CORP /DE/ (CELGZ) Delisted | see remarks | — | — | — | $0 | 1 | 2012-06-05 |
| MEDCO HEALTH SOLUTIONS INC (MHS) Delisted | Gen'l Counsel & Secretary, SVP | 0 | — | — | -$8.78M | 19 | 2012-04-03 |
Recent Filings
76 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-11 | ACI | Grant (A) | — | $0 | EDGAR |
| 2026-07-28 | ACI | Buy (P) | +170,500 | $1.96M | EDGAR |
| 2026-05-12 | ACI | Grant (A) | — | $0 | EDGAR |
| 2026-04-23 | ACI | Mixed | +44,691 | $1.42M | EDGAR |
| 2026-04-20 | ACI | Mixed | — | $0 | EDGAR |
| 2026-04-09 | ACI | Exer (M) | — | $0 | EDGAR |
| 2026-03-04 | ACI | Mixed | +59,768 | $1.07M | EDGAR |
| 2026-02-10 | ACI | Grant (A) | — | $0 | EDGAR |
| 2025-12-04 | ACI | Exer (M) | — | $0 | EDGAR |
| 2025-11-10 | ACI | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.